Completed PHASE1/PHASE2 INTERVENTIONAL 4-arm NCT00879138

Efficacy and Safety of VA106483 in Elderly Males

A Double-blind, Placebo-controlled Dose Response Study to Investigate Pharmacodynamics and Pharmacokinetics of Single and Repeated Oral Doses of VA106483 in Elderly Male Subjects

Sponsor: Vantia Ltd

Conditions Nocturia

Interventions Sugar pill VA106483

Updated 8 times since 2017 Last updated: Oct 29, 2018 Started: Aug 31, 2008 Primary completion: Feb 28, 2009 Completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Nocturia and is currently completed. Vantia Ltd leads this study, which shows 8 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE1_PHASE2
Nov 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 3 earlier versions

Jul 2018 — Nov 2018 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jul 2018 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vantia Ltd
Veeda Clinical Research

Data source: Vantia Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Plymouth, United Kingdom